BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 10822080)

  • 1. An inhibitor of activated thrombin-activatable fibrinolysis inhibitor potentiates tissue-type plasminogen activator-induced thrombolysis in a rabbit jugular vein thrombolysis model.
    Nagashima M; Werner M; Wang M; Zhao L; Light DR; Pagila R; Morser J; Verhallen P
    Thromb Res; 2000 May; 98(4):333-42. PubMed ID: 10822080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel approach to arterial thrombolysis.
    Klement P; Liao P; Bajzar L
    Blood; 1999 Oct; 94(8):2735-43. PubMed ID: 10515877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombin activatable fibrinolysis inhibitor (TAFI) does not inhibit in vitro thrombolysis by pharmacological concentrations of t-PA.
    Colucci M; D'Aprile AM; Italia A; Gresele P; Morser J; Semeraro N
    Thromb Haemost; 2001 Apr; 85(4):661-6. PubMed ID: 11341502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombotic effects due to pharmacological modulation of thrombin-activatable fibrinolysis inhibitor in rats.
    Soni H; Sharma A; Bhatt S; Jain MR; Patel PR
    Pharmacology; 2008; 82(4):304-9. PubMed ID: 18936552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-administration of a carboxypeptidase inhibitor enhances tPA-induced thrombolysis in mouse microthrombi: Evidence from intravital imaging analysis.
    Mathews NS; Suzuki Y; Honkura N; Sano H; Iwashita T; Urano T
    Thromb Res; 2022 Feb; 210():78-86. PubMed ID: 35030422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrinolytic efficacy of Amediplase, Tenecteplase and scu-PA in different external plasma clot lysis models: sensitivity to the inhibitory action of thrombin activatable fibrinolysis inhibitor (TAFI).
    Guimarães AH; Barrett-Bergshoeff MM; Criscuoli M; Evangelista S; Rijken DC
    Thromb Haemost; 2006 Sep; 96(3):325-30. PubMed ID: 16953274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative thrombolytic properties of tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (u-PA) and K1K2Pu (a t-PA/u-PA chimera) in a combined arterial and venous thrombosis model in the dog.
    Lu HR; Wu Z; Pauwels P; Lijnen HR; Collen D
    J Am Coll Cardiol; 1992 May; 19(6):1350-9. PubMed ID: 1342779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dabigatran enhances clot susceptibility to fibrinolysis by mechanisms dependent on and independent of thrombin-activatable fibrinolysis inhibitor.
    Ammollo CT; Semeraro F; Incampo F; Semeraro N; Colucci M
    J Thromb Haemost; 2010 Apr; 8(4):790-8. PubMed ID: 20088944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombin activatable fibrinolysis inhibitor (TAFI) affects fibrinolysis in a plasminogen activator concentration-dependent manner. Study of seven plasminogen activators in an internal clot lysis model.
    Guimarães AH; Rijken DC
    Thromb Haemost; 2004 Mar; 91(3):473-9. PubMed ID: 14983222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A direct oral anticoagulant edoxaban accelerated fibrinolysis via enhancement of plasmin generation in human plasma: dependent on thrombin-activatable fibrinolysis inhibitor.
    Morishima Y; Honda Y
    J Thromb Thrombolysis; 2019 Jul; 48(1):103-110. PubMed ID: 30972711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha 2-antiplasmin supplementation inhibits tissue plasminogen activator-induced fibrinogenolysis and bleeding with little effect on thrombolysis.
    Weitz JI; Leslie B; Hirsh J; Klement P
    J Clin Invest; 1993 Apr; 91(4):1343-50. PubMed ID: 7682569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombolytic and haemorrhagic effects of bolus doses of tissue-type plasminogen activator and a hybrid plasminogen activator with prolonged plasma half-life (K2tu-PA: CGP 42935).
    Agnelli G; Pascucci C; Nenci GG; Mele A; Bürgi R; Heim J
    Thromb Haemost; 1993 Aug; 70(2):294-300. PubMed ID: 8236138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombin-activable fibrinolysis inhibitor zymogen does not play a significant role in the attenuation of fibrinolysis.
    Foley JH; Kim P; Nesheim ME
    J Biol Chem; 2008 Apr; 283(14):8863-7. PubMed ID: 18252711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombolysis with human extrinsic (tissue-type) plasminogen activator in rabbits with experimental jugular vein thrombosis. Effect of molecular form and dose of activator, age of the thrombus, and route of administration.
    Collen D; Stassen JM; Verstraete M
    J Clin Invest; 1983 Feb; 71(2):368-76. PubMed ID: 6681615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrin-specific fibrinolysis induced by recombinant staphylokinase.
    Shishido Y; Matsumoto T; Sakai M; Kaneda N; Sansawa H; Shimura K; Hashimoto S; Yokokura T
    Biol Pharm Bull; 1994 Aug; 17(8):1060-4. PubMed ID: 7820108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine model of ferric chloride-induced vena cava thrombosis: evidence for effect of potato carboxypeptidase inhibitor.
    Wang X; Smith PL; Hsu MY; Ogletree ML; Schumacher WA
    J Thromb Haemost; 2006 Feb; 4(2):403-10. PubMed ID: 16420573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombus lysis by uPA, scuPA and tPA is regulated by plasma TAFI.
    Mutch NJ; Moore NR; Wang E; Booth NA
    J Thromb Haemost; 2003 Sep; 1(9):2000-7. PubMed ID: 12941043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demonstration of enhanced endogenous fibrinolysis in thrombin activatable fibrinolysis inhibitor-deficient mice.
    Mao SS; Holahan MA; Bailey C; Wu G; Colussi D; Carroll SS; Cook JJ
    Blood Coagul Fibrinolysis; 2005 Sep; 16(6):407-15. PubMed ID: 16093731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel inhibitor of activated thrombin activatable fibrinolysis inhibitor (TAFIa) - part II: enhancement of both exogenous and endogenous fibrinolysis in animal models of thrombosis.
    Wang YX; da Cunha V; Vincelette J; Zhao L; Nagashima M; Kawai K; Yuan S; Emayan K; Islam I; Hosoya J; Sullivan ME; Dole WP; Morser J; Buckman BO; Vergona R
    Thromb Haemost; 2007 Jan; 97(1):54-61. PubMed ID: 17200771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of ultrasound on tissue-type plasminogen activator-induced thrombolysis.
    Lauer CG; Burge R; Tang DB; Bass BG; Gomez ER; Alving BM
    Circulation; 1992 Oct; 86(4):1257-64. PubMed ID: 1394932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.